MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/vaccines10050763

Медицинская библиотека · Vaccines · 2022

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

Czarnowska Agata, Tarasiuk Joanna, Zajkowska Olga, Wnuk Marcin, Marona Monika, Nowak Klaudia, Słowik Agnieszka, Jamroz-Wiśniewska Anna, Rejdak Konrad, Lech Beata, Popiel Małgorzata, Rościszewska-Żukowska Iwona, Perenc Adam, Bartosik-Psujek Halina, Świderek-Matysiak Mariola, Siger Małgorzata, Ciach Agnieszka, Walczak Agata, Jurewicz Anna, Stasiołek Mariusz, Kania Karolina, Dyczkowska Klara, Kalinowska-Łyszczarz Alicja, Galus Weronika, Walawska-Hrycek Anna, Krzystanek Ewa, Chojdak-Łukasiewicz Justyna, Ubysz Jakub, Pokryszko-Dragan Anna, Kapica-Topczewska Katarzyna, Chorąży Monika, Bazylewicz Marcin, Mirończuk Anna, Kulikowska Joanna, Kochanowicz Jan, Białek Marta, Stolarz Małgorzata, Kubicka-Bączyk Katarzyna, Niedziela Natalia, Morawiec Natalia, Adamczyk-Sowa Monika, Podlecka-Piętowska Aleksandra, Nojszewska Monika, Zakrzewska-Pniewska Beata, Jasińska Elżbieta, Zaborski Jacek, Milewska-Jędrzejczak Marta, Zwiernik Jacek, Zwiernik Beata, Potemkowski Andrzej, Brola Waldemar, Kułakowska Alina

СтатьяПеревод в очереди

Аннотация

(1)

Background

The present study aims to report the side effects of vaccination against coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) who were being treated with disease-modifying therapies (DMTs) in Poland. (2)

Methods

The study included 2261 patients with MS who were being treated with DMTs, and who were vaccinated against COVID-19 in 16 Polish MS centers. The data collected were demographic information, specific MS characteristics, current DMTs, type of vaccine, side effects after vaccination, time of side-effect symptom onset and resolution, applied treatment, relapse occurrence, and incidence of COVID-19 after vaccination. The results were presented using maximum likelihood estimates of the odds ratio, t-test, Pearson's chi-squared test, Fisher's exact p, and logistic regression. The statistical analyses were performed using STATA 15 software. (3) Of the 2261 sampled patients, 1862 (82.4%) were vaccinated with nucleoside-modified messenger RNA (mRNA) vaccines. Mild symptoms after immunization, often after the first dose, were reported in 70.6% of individuals. Symptoms included arm pain (47.5% after the first dose and 38.7% after the second dose), fever/chills/flu-like symptoms (17.1% after the first dose and 20.5% after the second dose), and fatigue (10.3% after the first dose and 11.3% after the second dose). Only one individual presented with severe side effects (pro-thrombotic complications) after vaccination. None of the DMTs in the presented cohort were predisposed to the development of side effects. Nine patients (0.4%) had a SARS-CoV-2 infection confirmed despite vaccination. (4)

Conclusions

Vaccination against SARS-CoV-2 is safe for people with MS who are being treated with DMTs. Most adverse events following vaccination are mild and the acute relapse incidence is low.

Для цитирования: Czarnowska Agata, Tarasiuk Joanna, Zajkowska Olga, Wnuk Marcin, Marona Monika, Nowak Klaudia, Słowik Agnieszka, Jamroz-Wiśniewska Anna, Rejdak Konrad, Lech Beata, Popiel Małgorzata, Rościszewska-Żukowska Iwona, Perenc Adam, Bartosik-Psujek Halina, Świderek-Matysiak Mariola, Siger Małgorzata, Ciach Agnieszka, Walczak Agata, Jurewicz Anna, Stasiołek Mariusz, Kania Karolina, Dyczkowska Klara, Kalinowska-Łyszczarz Alicja, Galus Weronika, Walawska-Hrycek Anna, Krzystanek Ewa, Chojdak-Łukasiewicz Justyna, Ubysz Jakub, Pokryszko-Dragan Anna, Kapica-Topczewska Katarzyna, Chorąży Monika, Bazylewicz Marcin, Mirończuk Anna, Kulikowska Joanna, Kochanowicz Jan, Białek Marta, Stolarz Małgorzata, Kubicka-Bączyk Katarzyna, Niedziela Natalia, Morawiec Natalia, Adamczyk-Sowa Monika, Podlecka-Piętowska Aleksandra, Nojszewska Monika, Zakrzewska-Pniewska Beata, Jasińska Elżbieta, Zaborski Jacek, Milewska-Jędrzejczak Marta, Zwiernik Jacek, Zwiernik Beata, Potemkowski Andrzej, Brola Waldemar, Kułakowska Alina. Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.. Vaccines. 2022. DOI: 10.3390/vaccines10050763.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.